Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 2 OF 155 | DISPLAYING 16 - 30 OF 2318 RESULTS

    Lim J. et. al., Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3, 10.1038/sdata.2018.283, Sci. Data, Dec 11, 2018

    Park D.M. et. al., The UzcRS two‐component system in Caulobacter crescentus integrates regulatory input from diverse auxiliary regulators , 10.1111/mmi.14180, Molecular Microbiology, Dec 08, 2018

    Grabosch S. et. al., Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles, https://doi.org/10.1038/s41388-018-0581-9, Oncogene, Dec 05, 2018

    Ryota H. et. al., Clinicopathological and immunological features of follicular pancreatitis—a distinct disease entity characterized by Th17 activation, 10.1111/his.13802, Histopathology, Dec 04, 2018

    Ennishi D. et. al., Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma., 10.1200/JCO.18.01583., J. Clin. Oncol., Dec 03, 2018

    Goschzik T. et. al., Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial, 10.1016/S1470-2045(18)30532-1, Lancet Oncol., Dec 03, 2018

    Freedman J.D. et. al., An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells, 10.1158/0008-5472.CAN-18-1750, Cancer Res., Dec 01, 2018

    Mottok A. et. al., Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens, 10.1182/blood-2018-05-851154 , Blood, Dec 01, 2018

    Lambros L. et. al., NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?, 10.5858/arpa.2018-0251-LE., Arch Pathol Lab Med., Dec 01, 2018

    Hillen L.M. et. al., Molecular profiling of Spitz nevi identified by digital RNA counting., 10.1097/CMR.0000000000000495., Melanoma Res., Dec 01, 2018

    Christmas B.J. et. al., Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs, 10.1158/2326-6066.CIR-18-0070, Can. Immunol. Res., Dec 01, 2018

    Menon D.R. et. al., CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma, 10.1158/0008-5472.CAN-18-0330, Cancer Res., Dec 01, 2018

    Fan K. et. al., Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma, 10.1158/1078-0432.CCR-18-1184, Clin. Can Res., Dec 01, 2018

    Gomes B. et. al., Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy, 10.1158/1535-7163.MCT-17-1104, Mol. Can. Ther., Dec 01, 2018

    Tanaka H. et. al., Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer, 10.1158/1535-7163.MCT-17-1180, Mol. Can. Ther., Dec 01, 2018